An elevated level of TNFα inhibits tyrosine kinase activity and results in insulin resistance, which has an impact on worsening metabolic homeostasis (diabetes and dyslipidaemia) and, consequently, worse IBD symptoms [9]. This evidence concerns the gene TNF and diabetes mellitus.